CMS has published its final rule for Medicare Advantage and Part D in 2026, outlining a series of regulatory updates aimed at ...

Medicare does cover GLP-1 drugs when prescribed for conditions like diabetes and heart disease, but legislation from 2003 prohibits Medicare from covering drugs for weight loss. There is a ...

A new study found that spending on GLP-1 medications ... from 0.1% to 0.4% of the U.S. population, or an estimated 854,000 people. Despite the high cost, averaging $1,540 per prescription ...

The therapeutic potential of targeting glucagon-like peptide-1 (GLP-1) has become increasingly evident over the past 20 years, both as notable diabetes and weight loss drugs, such as exenatide, ...

Studies showed the supplement provides a 22% increase in GLP-1 levels, leading to fewer cravings and glucose spikes. The same data also showed an 11% decrease in insulin resistance. Within three ...

SAN DIEGO — GLP-1 agonists may lead to increased nausea and vomiting in the early postoperative period after total hip arthroplasty, according to results presented here. “Orthopedic surgeons ...

He recently wrote a primer on the new injectable weight loss drugs: “Ozempic, Risks, Benefits, and Natural Alternatives to GLP-1 Weight-Loss Drugs.” This column is a summary. GLP-1 is short for ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation ...

Although grateful for the recognition, she noted that this has been a huge team effort. “When you see a success story like GLP-1, there are multiple inventors.” In the 1980s, Habener was working at ...

The decision counters a proposal by the Biden Administration to reimburse beneficiaries for the weight-loss medications.

OneSource Specialty Pharma Limited, an Indian contract development and manufacturing organisation (CDMO), is gearing up to capture a 15-20% share in the generic GLP-1 market by FY27-28 ...